ABVC BioPharma, Inc. (ABVC)
1.01
-0.03
(-2.88%)
USD |
NASDAQ |
Oct 30, 16:00
1.01
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Total Return Level : 1.04 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 1.04 |
| October 28, 2026 | 1.09 |
| October 27, 2026 | 1.05 |
| October 26, 2026 | 1.05 |
| October 23, 2026 | 1.04 |
| October 22, 2026 | 1.047 |
| October 21, 2026 | 1.00 |
| October 20, 2026 | 0.93 |
| October 19, 2026 | 0.91 |
| October 16, 2026 | 0.9179 |
| October 15, 2026 | 0.9325 |
| October 14, 2026 | 1.02 |
| October 13, 2026 | 0.979 |
| October 12, 2026 | 0.9798 |
| October 09, 2026 | 1.00 |
| October 08, 2026 | 0.98 |
| October 07, 2026 | 1.00 |
| October 06, 2026 | 0.97 |
| October 05, 2026 | 0.98 |
| October 02, 2026 | 1.01 |
| October 01, 2026 | 1.02 |
| September 30, 2026 | 1.06 |
| September 29, 2026 | 1.04 |
| September 28, 2026 | 1.05 |
| September 25, 2026 | 1.13 |
| Date | Value |
|---|---|
| September 24, 2026 | 1.09 |
| September 23, 2026 | 1.14 |
| September 22, 2026 | 1.16 |
| September 21, 2026 | 1.15 |
| September 18, 2026 | 1.16 |
| September 17, 2026 | 1.15 |
| September 16, 2026 | 1.08 |
| September 15, 2026 | 1.07 |
| September 14, 2026 | 1.00 |
| September 11, 2026 | 0.9801 |
| September 10, 2026 | 0.9762 |
| September 09, 2026 | 0.97 |
| September 08, 2026 | 1.06 |
| September 04, 2026 | 0.9601 |
| September 03, 2026 | 1.00 |
| September 02, 2026 | 0.8645 |
| September 01, 2026 | 0.8254 |
| August 31, 2026 | 0.8575 |
| August 28, 2026 | 0.83 |
| August 27, 2026 | 0.7957 |
| August 26, 2026 | 0.711 |
| August 25, 2026 | 0.7999 |
| August 24, 2026 | 0.84 |
| August 21, 2026 | 0.8982 |
| August 20, 2026 | 0.8982 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Anika Therapeutics, Inc. | 21.79 |
| Perspective Therapeutics, Inc. | 1.17 |
| MiMedx Group, Inc. | 3.97 |
| Abbott Laboratories | 235.85 |
| AngioDynamics, Inc. | 12.35 |